Literature DB >> 7672663

Parallel interleukin 5 synthesis by eosinophils in duodenal and skin lesions of a patient with dermatitis herpetiformis.

P Desreumaux1, A Janin, E Delaporte, S Dubucquoi, F Piette, A Cortot, M Capron, J F Colombel.   

Abstract

A 59 year old man is presented with a diagnosis of dermatitis herpetiformis. Duodenal and skin biopsy specimens from blisters of both recent and late onset were collected before treatment. Electron microscopy, immunohistochemistry, and in situ hybridisation were performed to analyse the presence of activated eosinophils and the local synthesis of interleukin 5 (IL5). Parallel state of eosinophil activation and IL5 synthesis was found in the duodenal mucosa with total flat mucosa and in skin vesicles of recent onset. It is suggested that duodenal and cutaneous eosinophils can synthesise IL5 and then participate in small bowel and skin lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672663      PMCID: PMC1382784          DOI: 10.1136/gut.37.1.132

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Inflammatory component of celiac sprue mucosa. I. Mast cells, basophils, and eosinophils.

Authors:  M N Marsh; J Hinde
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

Review 2.  Dermatitis herpetiformis. Clinical, histologic, therapeutic and laboratory clues.

Authors:  S I Katz
Journal:  Int J Dermatol       Date:  1978-09       Impact factor: 2.736

3.  Dermatitis herpetiformis: effect of gluten-restricted and gluten-free diet on dapsone requirement and on IgA and C3 deposits in uninvolved skin.

Authors:  K Ljunghall; U Tjernlund
Journal:  Acta Derm Venereol       Date:  1983       Impact factor: 4.437

4.  Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid.

Authors:  W K Blenkinsopp; G P Haffenden; L Fry; J N Leonard
Journal:  Am J Dermatopathol       Date:  1983-12       Impact factor: 1.533

5.  [Existence and function of a receptor for immunoglobulin A on human eosinophils].

Authors:  M Capron; M Tomassini; E Van der Vorst; J P Kusnierz; J P Papin; A Capron
Journal:  C R Acad Sci III       Date:  1988

6.  Dermatitis herpetiformis: the skin and the gut.

Authors:  S I Katz; R P Hall; T J Lawley; W Strober
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

7.  IL-2 mRNA expression in Tac-positive malignant lymphomas.

Authors:  M Peuchmaur; D Emilie; M C Crevon; P Solal-Celigny; M C Maillot; G Lemaigre; P Galanaud
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

8.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

9.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.

Authors:  Y Yamaguchi; T Suda; J Suda; M Eguchi; Y Miura; N Harada; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

10.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.